Detalhe da pesquisa
1.
Clinical and Immunological Impact of Ocrelizumab Extended Interval Dosing in Multiple Sclerosis: A Single-Center, Real-World Experience.
Int J Mol Sci
; 25(10)2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38791391
2.
Peripheral Biomarkers in Manifest and Premanifest Huntington's Disease.
Int J Mol Sci
; 24(7)2023 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37047023
3.
Case report: A novel mutation of glial fibrillary acidic protein gene causing juvenile-onset Alexander disease.
Front Neurol
; 15: 1362013, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38572490